115 related articles for article (PubMed ID: 21297204)
1. Effect of chronic angiotensin converting enzyme inhibitor therapy on myocardial injury in patients undergoing percutaneous coronary interventions.
Aleti S; Bansal D; Agrawal M; Uretsky BF; Sachdeva R
J Invasive Cardiol; 2011 Feb; 23(2):72-5. PubMed ID: 21297204
[TBL] [Abstract][Full Text] [Related]
2. Newly diagnosed and previously known diabetes mellitus and 1-year outcomes of acute myocardial infarction: the VALsartan In Acute myocardial iNfarcTion (VALIANT) trial.
Aguilar D; Solomon SD; Køber L; Rouleau JL; Skali H; McMurray JJ; Francis GS; Henis M; O'Connor CM; Diaz R; Belenkov YN; Varshavsky S; Leimberger JD; Velazquez EJ; Califf RM; Pfeffer MA
Circulation; 2004 Sep; 110(12):1572-8. PubMed ID: 15364810
[TBL] [Abstract][Full Text] [Related]
3. Effects of angiotensin-converting enzyme inhibitor or angiotensin receptor blocker therapy after hospital discharge on subsequent rehospitalization for acute myocardial infarction and heart failure.
Hess G; Preblick R; Hill J; Plauschinat CA; Yaskin J
Congest Heart Fail; 2009; 15(4):170-5. PubMed ID: 19627290
[TBL] [Abstract][Full Text] [Related]
4. Association of aspirin dosage to clinical outcomes after percutaneous coronary intervention: observations from the Ottawa Heart Institute PCI Registry.
So D; Cook EF; Le May M; Glover C; Williams W; Ha A; Davies R; Froeschl M; Marquis JF; O'Brien E; Labinaz M
J Invasive Cardiol; 2009 Mar; 21(3):121-7. PubMed ID: 19258643
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin receptor blockers versus ACE inhibitors: prevention of death and myocardial infarction in high-risk populations.
Epstein BJ; Gums JG
Ann Pharmacother; 2005 Mar; 39(3):470-80. PubMed ID: 15701766
[TBL] [Abstract][Full Text] [Related]
7. The effect of valsartan, captopril, or both on atherosclerotic events after acute myocardial infarction: an analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT).
McMurray J; Solomon S; Pieper K; Reed S; Rouleau J; Velazquez E; White H; Howlett J; Swedberg K; Maggioni A; Køber L; Van de Werf F; Califf R; Pfeffer M
J Am Coll Cardiol; 2006 Feb; 47(4):726-33. PubMed ID: 16487836
[TBL] [Abstract][Full Text] [Related]
8. Optimal medical management of peripheral arterial disease.
Rice TW; Lumsden AB
Vasc Endovascular Surg; 2006; 40(4):312-27. PubMed ID: 16959725
[TBL] [Abstract][Full Text] [Related]
9. Use of statins prior to percutaneous coronary intervention reduces myonecrosis and improves clinical outcome.
Chang SM; Yazbek N; Lakkis NM
Catheter Cardiovasc Interv; 2004 Jun; 62(2):193-7. PubMed ID: 15170709
[TBL] [Abstract][Full Text] [Related]
10. Retrospective claims database analysis to determine relationship between renin-angiotensin system agents, rehospitalization, and health care costs in patients with heart failure or myocardial infarction.
Sun SX; Ye X; Lee KY; Dupclay L; Plauschinat C
Clin Ther; 2008; 30 Pt 2():2217-27. PubMed ID: 19281916
[TBL] [Abstract][Full Text] [Related]
11. Preoperative Angiotensin-converting enzyme inhibitors and acute kidney injury after coronary artery bypass grafting.
Benedetto U; Sciarretta S; Roscitano A; Fiorani B; Refice S; Angeloni E; Sinatra R
Ann Thorac Surg; 2008 Oct; 86(4):1160-5. PubMed ID: 18805152
[TBL] [Abstract][Full Text] [Related]
12. Dual renin angiotensin system blockade in patients with acute myocardial infarction and preserved left ventricular systolic function.
Suşan M; Petrescu L; Riviş AI; Suşan RM; Burghină D; Dan R; Cozma D; Drăgulescu SI
Rom J Intern Med; 2005; 43(3-4):187-98. PubMed ID: 16812979
[TBL] [Abstract][Full Text] [Related]
13. [Old myocardial infarction--focus on complication and secondary prevention].
Fusazaki T
Nihon Rinsho; 2007 Sep; Suppl 5 Pt 2():202-9. PubMed ID: 17948700
[No Abstract] [Full Text] [Related]
14. Implications of diabetes in patients with acute coronary syndromes. The Global Registry of Acute Coronary Events.
Franklin K; Goldberg RJ; Spencer F; Klein W; Budaj A; Brieger D; Marre M; Steg PG; Gowda N; Gore JM;
Arch Intern Med; 2004 Jul; 164(13):1457-63. PubMed ID: 15249356
[TBL] [Abstract][Full Text] [Related]
15. Adverse events after stopping clopidogrel in post-acute coronary syndrome patients: Insights from a large integrated healthcare delivery system.
Ho PM; Tsai TT; Wang TY; Shetterly SM; Clarke CL; Go AS; Sedrakyan A; Rumsfeld JS; Peterson ED; Magid DJ
Circ Cardiovasc Qual Outcomes; 2010 May; 3(3):303-8. PubMed ID: 20354221
[TBL] [Abstract][Full Text] [Related]
16. Effects of receipt of chronic statin therapy before the onset of acute myocardial infarction: a retrospective study in patients undergoing primary percutaneous coronary intervention.
Ishii H; Ichimiya S; Kanashiro M; Aoyama T; Ogawa Y; Murakami R; Amano T; Naruse K; Matsubara T; Murohara T
Clin Ther; 2006 Nov; 28(11):1812-9. PubMed ID: 17213001
[TBL] [Abstract][Full Text] [Related]
17. The effect of the angiotensin-converting-enzyme inhibitor zofenopril on mortality and morbidity after anterior myocardial infarction. The Survival of Myocardial Infarction Long-Term Evaluation (SMILE) Study Investigators.
Ambrosioni E; Borghi C; Magnani B
N Engl J Med; 1995 Jan; 332(2):80-5. PubMed ID: 7990904
[TBL] [Abstract][Full Text] [Related]
18. The revised role of ACE-inhibition after myocardial infarction in the thrombolytic/primary PCI era.
de Kam PJ; Voors AA; Fici F; van Veldhuisen DJ; van Gilst WH
J Renin Angiotensin Aldosterone Syst; 2004 Dec; 5(4):161-8. PubMed ID: 15803434
[TBL] [Abstract][Full Text] [Related]
19. In-hospital and one-year outcomes of patients with high-risk acute myocardial infarction treated with thrombolysis or primary coronary angioplasty.
Steffenino G; Santoro GM; Maras P; Mauri F; Ardissino D; Violini R; Chiarella F; Lucci D; Marini M; Baldasseroni S; Maggioni AP;
Ital Heart J; 2004 Feb; 5(2):136-45. PubMed ID: 15086144
[TBL] [Abstract][Full Text] [Related]
20. [Angiotensin converting enzyme inhibitors in arterial hypertension].
Ramón González-Juanatey J
Rev Esp Cardiol; 1999; 52 Suppl 3():73-8. PubMed ID: 10614152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]